MJardin Group, Inc.
MJardin Group, Inc.
Your view on MJARF
Overview
What the company does, where it operates, and who runs it.
About MJardin Group, Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Ali Mahdavi
- Headquarters
- 1 Toronto Street, Toronto, ON, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Ali Mahdavi
- Headquarters
- 1 Toronto Street, Toronto, ON, CA
MJardin Group, Inc., through its subsidiaries, cultivates, harvests, processes, and sells cannabis products in Canada and the United States.
The company also provides consulting services, including strategic capital and financing, project management services for cultivation, licensure support, facility design, systems implementation, facility and equipment leasing, construction oversight, facility ramp-up, and access to intellectual property held by the company to licensed cannabis operators with cultivation and retail businesses.
It owns, manages, or advises on a portfolio of 32 cannabis operations. The company was founded in 2014 and is headquartered in Ontario, Canada.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
Fair value for MJardin Group, Inc. from FRC's valuation model, read against the market price. MJARF last traded at $0.0001; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for MJardin Group, Inc.. Starting points for MJardin Group, Inc.: EPS -$0.39, beta 1.67 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for MJardin Group, Inc.. MJardin Group, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for MJardin Group, Inc.. Trailing twelve-month EPS for MJardin Group, Inc. stands at -$0.39. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings Estimate
| EPS | Current QtrDec 2021 | Next QtrSep 2024 | Current YearFY Dec 2021 | Next YearFY Dec 2024 |
|---|---|---|---|---|
| Avg. estimate | -CAD 0.02 | CAD 0.00 | -CAD 0.11 | -CAD 0.10 |
| Low estimate | -CAD 0.02 | CAD 0.00 | -CAD 0.11 | -CAD 0.10 |
| High estimate | -CAD 0.02 | CAD 0.00 | -CAD 0.11 | -CAD 0.10 |
| No. of analysts | 1 | 0 | 1 | 1 |
| Year-ago EPS | -CAD 0.23 | -CAD 0.03 | -CAD 0.34 | — |
| Growth | +91.2% | +100.0% | +67.4% | — |
Revenue Estimate
| Revenue | Current QtrDec 2021 | Next QtrSep 2024 | Current YearFY Dec 2021 | Next YearFY Dec 2024 |
|---|---|---|---|---|
| Avg. estimate | CAD 8.46M | CAD 4.72M | CAD 28.70M | CAD 26.74M |
| Low estimate | CAD 8.46M | CAD 4.72M | CAD 28.70M | CAD 26.74M |
| High estimate | CAD 8.46M | CAD 4.72M | CAD 28.70M | CAD 26.74M |
| No. of analysts | 1 | 1 | 1 | 1 |
| Year-ago revenue | CAD 2.36M | CAD 1.28M | CAD 11.44M | — |
| Growth | +258.3% | +268.7% | +150.9% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 12, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for MJardin Group, Inc.. MJardin Group, Inc. has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
MJardin Group, Inc. valued side by side against its closest peers. MJardin Group, Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
News
Latest headlines and market coverage.
Latest headlines and company announcements for MJardin Group, Inc.. Coverage tracks MJardin Group, Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of MJardin Group, Inc.